Insider Trading Alert - Sherwin-Williams Company And 4 Others Traded By Insiders

Monday, July 8, 2013, 142 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $1.15 to $10,873,958.42.

Highlighted Stocks Traded by Insiders:

Sherwin-Williams Company (SHW) - FREE Research Report

Kadien Thomas G who is Director at SHERWIN WILLIAM bought 7,302 shares at $60.18 per share for a total value of $11,916.30 on July 5, 2013. Following this transaction, the Director owned 8,995 shares meaning that the stake was boosted by 431.31% with the 7,302 share acquisition.

Kramer Richard J who is Director at SHERWIN WILLIAM bought 2,558 shares at $90.28 per share for a total value of $23,832.60 on July 5, 2013. Following this transaction, the Director owned 2,853 shares meaning that the stake was boosted by 867.12% with the 2,558 share acquisition.

The shares most recently traded at $184.04, up $1.74, or 0.95% since the insider transactions. Historical insider transactions for Sherwin-Williams Company go as follows:

  • 12-Week # shares sold: 4,024
  • 24-Week # shares sold: 4,024

The average volume for Sherwin-Williams Company has been 683,400 shares per day over the past 30 days. Sherwin-Williams Company has a market cap of $18.8 billion and is part of the basic materials sector and chemicals industry. Shares are up 18.52% year to date as of the close of trading on Monday.

The Sherwin-Williams Company engages in the development, manufacture, distribution, and sale of paints, coatings, and related products to professional, industrial, commercial, and retail customers primarily in North America, South America, Europe, Asia, and the Caribbean region. The stock currently has a dividend yield of 1.1%. The company has a P/E ratio of 29.5. Currently there are 5 analysts that rate Sherwin-Williams Company a buy, 1 analyst rates it a sell, and 7 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on SHW - FREE

TheStreet Quant Ratings rates Sherwin-Williams Company as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, impressive record of earnings per share growth, notable return on equity, good cash flow from operations and expanding profit margins. Although no company is perfect, currently we do not see any significant weaknesses which are likely to detract from the generally positive outlook. Get the full Sherwin-Williams Company Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

Honeywell International (HON) - FREE Research Report

Adams Katherine L. who is Sr. VP & General Counsel at HONEYWELL INTL bought 2,306 shares at $39.59 per share for a total value of $12,116.07 on July 5, 2013. Following this transaction, the Sr. VP & General Counsel owned 82,173 shares meaning that the stake was boosted by 2.88% with the 2,306 share acquisition.

The shares most recently traded at $81.44, up $0.77, or 0.95% since the insider transaction. Historical insider transactions for Honeywell International go as follows:

  • 12-Week # shares sold: 15,449
  • 24-Week # shares sold: 128,208

The average volume for Honeywell International has been 3.3 million shares per day over the past 30 days. Honeywell International has a market cap of $63.0 billion and is part of the industrial goods sector and industrial industry. Shares are up 27.1% year to date as of the close of trading on Monday.

Honeywell International Inc. operates as a diversified technology and manufacturing company worldwide. The stock currently has a dividend yield of 2.05%. The company has a P/E ratio of 20.7. Currently there are 18 analysts that rate Honeywell International a buy, no analysts rate it a sell, and 4 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on HON - FREE

TheStreet Quant Ratings rates Honeywell International as a buy. The company's strengths can be seen in multiple areas, such as its impressive record of earnings per share growth, revenue growth, good cash flow from operations, solid stock price performance and largely solid financial position with reasonable debt levels by most measures. We feel these strengths outweigh the fact that the company shows low profit margins. Get the full Honeywell International Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

Consolidated Edison (ED) - FREE Research Report

Davis Gordon J who is Director at CONSOL EDISON bought 0 shares at $57.42 per share for a total value of $1.15 on June 30, 2013. Following this transaction, the Director owned 28,525 shares meaning that the stake was boosted by 0% with the 0 share acquisition.

Del Giudice Michael J who is Director at CONSOL EDISON bought 14 shares at $57.42 per share for a total value of $830.29 on June 30, 2013. Following this transaction, the Director owned 33,496 shares meaning that the stake was boosted by 0.04% with the 14 share acquisition.

Hoglund Robert N who is SVP & CFO at CONSOL EDISON bought 99 shares at $57.42 per share for a total value of $5,673.67 on June 30, 2013. Following this transaction, the SVP & CFO owned 35,050 shares meaning that the stake was boosted by 0.28% with the 99 share acquisition.

Ivey Craig S who is President (CECONY) at CONSOL EDISON bought 636 shares at $28.71 per share for a total value of $3,572.67 on June 30, 2013. Following this transaction, the President (CECONY) owned 44,155 shares meaning that the stake was boosted by 1.46% with the 636 share acquisition.

McAvoy John who is President & CEO, O&R at CONSOL EDISON bought 2,539 shares at $19.14 per share for a total value of $358.88 on June 30, 2013. Following this transaction, the President & CEO, O&R owned 13,064 shares meaning that the stake was boosted by 24.13% with the 2,539 share acquisition.

Moore Elizabeth D who is SVP & General Counsel at CONSOL EDISON bought 62 shares at $57.42 per share for a total value of $3,551.43 on June 30, 2013. Following this transaction, the SVP & General Counsel owned 16,447 shares meaning that the stake was boosted by 0.38% with the 62 share acquisition.

Muccilo Robert who is VP & Chief Accounting Officer at CONSOL EDISON bought 76 shares at $57.42 per share for a total value of $4,373.11 on June 30, 2013. Following this transaction, the VP & Chief Accounting Officer owned 3,582 shares meaning that the stake was boosted by 2.17% with the 76 share acquisition.

Nadkarni Gurudatta D who is VP, Strategic Planning at CONSOL EDISON bought 77 shares at $57.42 per share for a total value of $4,393.78 on June 30, 2013. Following this transaction, the VP, Strategic Planning owned 3,496 shares meaning that the stake was boosted by 2.24% with the 77 share acquisition.

Oates Joseph P who is SVP, Business Shared Services at CONSOL EDISON bought 22 shares at $57.42 per share for a total value of $1,272.43 on June 30, 2013. Following this transaction, the SVP, Business Shared Services owned 20,026 shares meaning that the stake was boosted by 0.11% with the 22 share acquisition.

Resheske Frances who is SVP, Public Affairs at CONSOL EDISON bought 237 shares at $28.71 per share for a total value of $58.57 on June 30, 2013. Following this transaction, the SVP, Public Affairs owned 40,418 shares meaning that the stake was boosted by 0.59% with the 237 share acquisition.

The shares most recently traded at $57.82, up $0.09, or 0.16% since the insider transactions. Historical insider transactions for Consolidated Edison go as follows:

  • 4-Week # shares bought: 206
  • 4-Week # shares sold: 3,335
  • 12-Week # shares bought: 517
  • 12-Week # shares sold: 6,838
  • 24-Week # shares bought: 1,740
  • 24-Week # shares sold: 6,838

The average volume for Consolidated Edison has been 1.9 million shares per day over the past 30 days. Consolidated Edison has a market cap of $16.7 billion and is part of the utilities sector and utilities industry. Shares are up 3.94% year to date as of the close of trading on Monday.

Consolidated Edison, Inc., through its subsidiaries, engages in regulated electric, gas, and steam delivery businesses. The stock currently has a dividend yield of 4.3%. The company has a P/E ratio of 16.0. Currently there are 2 analysts that rate Consolidated Edison a buy, 3 analysts rate it a sell, and 8 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on ED - FREE

TheStreet Quant Ratings rates Consolidated Edison as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, reasonable valuation levels and notable return on equity. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full Consolidated Edison Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

United Therapeutics Corporation (UTHR) - FREE Research Report

Causey Christopher who is Director at UTD THERAPEUTIC bought 3,450 shares at $32.50 per share for a total value of $146,250.00 on July 5, 2013. Following this transaction, the Director owned 3,416 shares meaning that the stake was boosted by 116.32% with the 3,450 share acquisition.

Jeffs Roger who is President & COO at UTD THERAPEUTIC bought 26,773 shares at $30.84 per share for a total value of $925,250.00 on July 5, 2013. Following this transaction, the President & COO owned 56,293 shares meaning that the stake was boosted by 54.07% with the 26,773 share acquisition.

Rothblatt Martine A who is CEO at UTD THERAPEUTIC bought 716,564 shares at $25.46 per share for a total value of $393,409.08 on July 5, 2013. Following this transaction, the CEO owned 712,981 shares meaning that the stake was boosted by 17295.78% with the 716,564 share acquisition.

The shares most recently traded at $67.97, down $0.17, or 0.25% since the insider transactions. Historical insider transactions for United Therapeutics Corporation go as follows:

  • 24-Week # shares sold: 7,666

The average volume for United Therapeutics Corporation has been 676,800 shares per day over the past 30 days. United Therapeutics Corporation has a market cap of $3.3 billion and is part of the health care sector and drugs industry. Shares are up 25.81% year to date as of the close of trading on Monday.

United Therapeutics Corporation, a biotechnology company, focuses on the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening conditions worldwide. The company has a P/E ratio of 10.7. Currently there are 3 analysts that rate United Therapeutics Corporation a buy, 1 analyst rates it a sell, and 7 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on UTHR - FREE

TheStreet Quant Ratings rates United Therapeutics Corporation as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures, solid stock price performance, attractive valuation levels and good cash flow from operations. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full United Therapeutics Corporation Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

Worthington Industries (WOR) - FREE Research Report

Karmanos Peter who is Director at WORTHINGTON IND bought 4,000 shares at $12.60 per share for a total value of $50,400.00 on July 5, 2013. Following this transaction, the Director owned 77,300 shares meaning that the stake was boosted by 5.46% with the 4,000 share acquisition.

The shares most recently traded at $34.34, up $0.89, or 2.66% since the insider transaction. Historical insider transactions for Worthington Industries go as follows:

  • 24-Week # shares sold: 100

The average volume for Worthington Industries has been 484,300 shares per day over the past 30 days. Worthington Industries has a market cap of $2.4 billion and is part of the industrial goods sector and industrial industry. Shares are up 28.7% year to date as of the close of trading on Monday.

Worthington Industries, Inc. operates as a diversified metals processing company that focuses on steel processing and manufactured metal products in the United States, Canada, Europe, and internationally. The stock currently has a dividend yield of 1.8%. The company has a P/E ratio of 17.5. Currently there are 2 analysts that rate Worthington Industries a buy, no analysts rate it a sell, and 3 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on WOR - FREE

TheStreet Quant Ratings rates Worthington Industries as a buy. The company's strengths can be seen in multiple areas, such as its solid stock price performance, good cash flow from operations, largely solid financial position with reasonable debt levels by most measures and notable return on equity. We feel these strengths outweigh the fact that the company shows low profit margins. Get the full Worthington Industries Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

Data for this article provided by Zacks Investment Research

null

More from Markets

NYSE Suspends Trading for Some Shares of Amazon, Alphabet

NYSE Suspends Trading for Some Shares of Amazon, Alphabet

Stocks Slide Amid a Rise in Bond Yields, Strong Earnings

Stocks Slide Amid a Rise in Bond Yields, Strong Earnings

Video: Jim Cramer Reveals Why He's Cautious on Stocks

Video: Jim Cramer Reveals Why He's Cautious on Stocks

Jim Cramer on Earnings: All Stories Aren't Equal

Jim Cramer on Earnings: All Stories Aren't Equal

4 Stocks Making Important Moves Wednesday

4 Stocks Making Important Moves Wednesday